Jonathan Kornstein Interview OCT East Coast: Trials in China

China’s evolving regulatory and funding environment is creating new opportunities for global clinical research. Access to large, often untapped patient populations, combined with more competitive study startup timelines, can make China an important consideration for sponsors seeking to expand enrollment and reduce development risk.